Kappa Bioscience

Kappa Bioscience AS, founded in 2006 and based in Oslo, Norway, specializes in the development and production of vitamin K2, specifically menaquinone-7 (MK-7), marketed under the K2VITAL brand. The company offers a variety of products, including microencapsulated DELTA for stability in mineral formulations, and various delivery forms such as MCC powder, MCT oil, and DEX powder. Kappa Bioscience serves manufacturers in the food supplement and fortified food markets, providing innovative solutions that enhance ingredient stability and purity. Through its wholly-owned division, Kappa Ingredients GmbH, the company manages global sales and distribution, ensuring a reliable supply chain and promoting the health benefits of vitamin K2 for bone, joint, and cardiovascular health. Kappa Bioscience's advancements in MK-7 synthesis have positioned it as a leader in the nutraceutical ingredients sector, facilitating broader consumer adoption of this essential vitamin.